Contact
🔒 Contacts are masked. Get full emails & phones. Unlock via export ↗
Category
Primary
lung-and-respiratory-health · embed-ft 0.35
Tree path
Medical Health › Diseases and Conditions › Lung and Respiratory Health
Group (tier-1)
AI readiness
AI training policy
allowed
AI-bot protection
AI files
Evidence
llms.txt
Compliance (GEO / GDPR)
TLD
Overview
Title
Targeting Fibrosis By Inhibiting Chemotaxis | Fibraxis
Description
Fibraxis is developing a first-in-class daily inhaler to halt and reverse structural lung damage in asthma, offering a new future in respiratory care.
Final URL
Language
en (html)
Scanned at
2026-06-22 01:22:46